During Monday’s Current trade, Shares of salesforce.com, inc. (NYSE:CRM), lost -0.35% to $73.04.
Salesforce (CRM), the Customer Success Platform and world’s #1 CRM company, declared that its second quarter fiscal 2016 results will be released on Thursday, Aug. 20, 2015, after the close of the market. The company will host a conference call at 2:00 p.m. (PDT) / 5:00 p.m. (EDT) to talk about its financial results with the investment community.
salesforce.com, inc. provides enterprise cloud computing solutions, with a focus on customer relationship administration to various businesses and industries worldwide. The company offers enterprise cloud computing apps and platform services, counting Sales Cloud for sales force automation, which enables companies to store data, access accurate customer and prospect information, track leads and progress, forecast opportunities, and collaborate around any sale on desktop and mobile devices; Service Cloud that enables companies to connect address customers service and support needs; and Marketing Cloud, which enables companies to map customer journeys to digital marketing interactions through email, mobile, social, Web, and connected products.
Shares of Keryx Biopharmaceuticals (NASDAQ:KERX), declined -3.01% to $7.73, during its current trading session.
Keryx Biopharmaceuticals, Inc. (KERX), a biopharmaceutical company focused on bringing innovative therapies to market for people with renal disease, declared that it will host a conference call and webcast on Wednesday, August 5, 2015 at 8:00 a.m. ET to talk about its second quarter 2015 financial results and provide a review of the Auryxia(TM) launch.
Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on providing therapies for patients with renal disease in the United States. Its lead product Auryxia (ferric citrate), an oral, ferric iron-based compound that has the capacity to bind to phosphate in the gastrointestinal tract and form non-absorbable complexes, in addition to treats iron deficiency anemia. Auryxia is also used to control serum phosphorus levels in patients with chronic kidney disease on dialysis.
B/E Aerospace Inc (NASDAQ:BEAV), during its Monday’s current trading session gained 1.71% to $49.54.
B/E Aerospace, Inc. (BEAV), the world’s leading manufacturer of aircraft cabin interior products, declared that its Board of Directors declared a quarterly dividend of $0.19 per outstanding share of the Company’s common stock. The dividend is payable on September 11, 2015 to shareholders of record at the close of business on August 17, 2015. In addition, the Company declared that it plans to initiate repurchases under its formerly authorized share repurchase program.
B/E Aerospace, Inc. designs, manufactures, sells, and services cabin interior products for commercial aircraft and business jets in the United States and internationally. Its Commercial Aircraft segment offers first class, business class, tourist class, and regional aircraft seats, in addition to spares; oxygen storage, distribution, and delivery systems for commercial and business jet aircraft; coffee makers/water boilers, ovens, and refrigeration equipment; and modular lavatory, wastewater, and galley systems.
Finally, Real Goods Solar, Inc. - Class A (NASDAQ:RGSE), gained 7.80%, to $1.85.
RGS Energy (RGSE), one of the nation’s leading rooftop installers of solar equipment, will hold a conference call on Monday, August 10, 2015 at 4:30 p.m. Eastern time to talk about results for the second quarter ended June 30, 2015. The financial results will be issued in a press release preceding to the call.
Real Goods Solar, Inc. operates as a residential and commercial solar energy engineering, procurement, and construction company in the United States. It operates in three segments: Residential, Sunetric, and Other. The company offers solar energy services, counting design, procurement, permitting, build-out, grid connection, financing referrals, and warranty and customer satisfaction.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
